Table 1.
Antibodies to ATP6S1 increase in response to immunotherapy
| Patient | Fold increase |
|---|---|
| Melanoma | |
| K007 | 3 |
| K008 | 12 |
| K023 | 3 |
| K030 | 8 |
| NSCLC | |
| L1 | 4 |
| L11 | 4 |
| L33 | 3 |
| CML | |
| C1 | 6 |
The vaccinated patients who did not show treatment-induced increases had detectable antibodies at 1:500–1:2,000 dilutions.